Delie F - Search Results

1

Malignant ascites: a source of therapeutic protein against ovarian cancer?

Ribaux P, Britan A, Thumann G, Delie F, Petignat P, Cohen M. Ribaux P, et al. Among authors: delie f. Oncotarget. 2019 Oct 15;10(57):5894-5905. doi: 10.18632/oncotarget.27185. eCollection 2019 Oct 15. Oncotarget. 2019. PMID: 31666922 Free PMC article.

2

GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach.

Delie F, Petignat P, Cohen M. Delie F, et al. J Oncol. 2012;2012:468615. doi: 10.1155/2012/468615. Epub 2012 Mar 18. J Oncol. 2012. PMID: 22481929 Free PMC article.

3

Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer?

Delie F, Ribaux P, Petignat P, Cohen M. Delie F, et al. Biochimie. 2012 Nov;94(11):2391-7. doi: 10.1016/j.biochi.2012.06.010. Epub 2012 Jun 17. Biochimie. 2012. PMID: 22713763

4

GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78.

Delie F, Petignat P, Cohen M. Delie F, et al. Target Oncol. 2013 Dec;8(4):225-30. doi: 10.1007/s11523-012-0234-9. Epub 2012 Oct 23. Target Oncol. 2013. PMID: 23090204

5

Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells.

Cohen M, Pierredon S, Wuillemin C, Delie F, Petignat P. Cohen M, et al. Among authors: delie f. Oncoscience. 2014 Apr 30;1(4):262-71. doi: 10.18632/oncoscience.31. eCollection 2014. Oncoscience. 2014. PMID: 25594018 Free PMC article.

6

Role of PAR-4 in ovarian cancer.

Meynier S, Kramer M, Ribaux P, Tille JC, Delie F, Petignat P, Cohen M. Meynier S, et al. Among authors: delie f. Oncotarget. 2015 Sep 8;6(26):22641-52. doi: 10.18632/oncotarget.4010. Oncotarget. 2015. PMID: 26246468 Free PMC article.

7

Circulating GRP78 antibodies from ovarian cancer patients: a promising tool for cancer cell targeting drug delivery system?

Van Hoesen K, Meynier S, Ribaux P, Petignat P, Delie F, Cohen M. Van Hoesen K, et al. Among authors: delie f. Oncotarget. 2017 Nov 11;8(63):107176-107187. doi: 10.18632/oncotarget.22412. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291021 Free PMC article.

8

PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment.

Fraguas-Sánchez AI, Torres-Suárez AI, Cohen M, Delie F, Bastida-Ruiz D, Yart L, Martin-Sabroso C, Fernández-Carballido A. Fraguas-Sánchez AI, et al. Among authors: delie f. Pharmaceutics. 2020 May 9;12(5):439. doi: 10.3390/pharmaceutics12050439. Pharmaceutics. 2020. PMID: 32397428 Free PMC article.

9

Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles.

Fraguas-Sánchez AI, Fernández-Carballido A, Delie F, Cohen M, Martin-Sabroso C, Mezzanzanica D, Figini M, Satta A, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Among authors: delie f. Eur J Pharm Biopharm. 2020 Sep;154:246-258. doi: 10.1016/j.ejpb.2020.07.008. Epub 2020 Jul 17. Eur J Pharm Biopharm. 2020. PMID: 32682943

10

NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer?

Ribaux P, Wuillemin C, Petignat P, Delie F, Cohen M. Ribaux P, et al. Among authors: delie f. Heliyon. 2023 Feb 12;9(2):e13676. doi: 10.1016/j.heliyon.2023.e13676. eCollection 2023 Feb. Heliyon. 2023. PMID: 36873150 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters